Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal… (NCT07164326) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients
100 participantsStarted 2025-10-15
Plain-language summary
Dexmedetomidine nebulization in sever preeclamptic patients
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with severe pre-eclampsia scheduled for cesarean section under general anesthesia
* ASA II, III
Exclusion Criteria:
* sever obesity (BMI ≥ 40)
* Cardiac patients
* History of diabetes mellitus
* Renal dysfunction (elevated serum creatinine \> 2mg\\dl)
* hepatic dysfunction (elevated hepatic enzyme three times above normal)
* History to hypersensitivity to the tested drug.
* Emergency surgery
* Known fetal anomalies
What they're measuring
1
Systolic blood pressure in response to endotracheal intubation